A new report from Hims & Hers underscores the urgency of weight loss for Americans as companies race to distribute weight loss medications.
GoodRx data shows that Americans overspent $200 million on weight loss medications like Ozempic and Wegovy.
Echelon has been a fitness industry player since 2017—and now it’s leveling up with ActiveMD, offering customers access to weight loss drugs.
Noom has partnered with Prism Labs to give GLP-1 users a way to monitor and track body composition and muscle mass.
Sima Sistani is out as CEO of WeightWatchers after leading the weight loss company for two years. Tara Comonte will serve as interim CEO.
Here’s the trends XRC, a venture capital firm, says will continue fueling the vitamins, minerals and supplement space
GLP-1 Drugs Like Ozempic will now be more tolerable thanks to metabolic health brand SoWell’s latest launch
The weight-loss solutions company is filling the gap between medications and nutrition with its Custom Meal Plans
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
Luxury fitness brand Equinox is creating a program designed to help Ozempic and Wegovy users build long-term, healthy habits.
Sign Up to Our Newsletter
